BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32658414)

  • 1. Prognostic and Clinicopathological Significance of Long Noncoding RNA GHET1 in Human Solid Tumors: a Meta-Analysis.
    Zeng L; Yang M; Gao D; Li N
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of LncRNA GHET1 expression in various cancers: a systematic review and meta-analysis.
    Ye J; Sun H; Feng Z; Zhang Q; Xia Y; Ji Y; Zhang Q
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31227613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers.
    Jiang YF; Zhang HY; Ke J; Shen H; Ou HB; Liu Y
    J Cell Mol Med; 2019 Aug; 23(8):4891-4899. PubMed ID: 31251476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis.
    Poursheikhani A; Nokhandani N; Yousefi H; Rad DM; Sahebkar A
    Curr Pharm Biotechnol; 2020; 21(14):1422-1432. PubMed ID: 32720600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Expression of Gastric Carcinoma High Expressed Transcript 1 is a Diagnostic and Prognostic Biomarker in Human Cancer.
    Wang H; Meng F; Dong S
    J Natl Med Assoc; 2020 Dec; 112(6):602-612. PubMed ID: 32653201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese Cancer Outcome: A Meta-Analysis.
    Song J; Chen X; Tian Q; Lun L; Wang Q; Wang H; Li X; Liu Z; Tian L; Jing X; Zhang Y; Tian R
    Dis Markers; 2019; 2019():5824190. PubMed ID: 31885739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and Prognostic Value of Gastric Carcinoma Highly Expressed Transcript 1 in Cancer: A Meta-Analysis.
    Zhou X; Fan Y; He Y; Mou A; Wang F; Liu Y; Wu Z
    J Oncol; 2020; 2020():6341093. PubMed ID: 32908508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of long non-coding RNA GHET1 in cancers: a systematic review and meta-analysis.
    Wang D; Zhang H; Fang X; Zhang X; Liu H
    Cancer Cell Int; 2020; 20():109. PubMed ID: 32280301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of lncRNA loc285194 as an independent prognostic marker in cancer: A systematic review and meta-analysis.
    Mehrad-Majd H; Ravanshad S; Moradi A; Khansalar N; Sheikhi M; Akhtari J
    Pathol Res Pract; 2019 Jun; 215(6):152426. PubMed ID: 31054796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of long non-coding RNA UCA1 in human solid tumors.
    Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C
    Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of long non-coding RNA breast cancer anti-estrogen resistance 4 in human cancers: A meta-analysis.
    Meng Y; Liu YL; Li K; Fu T
    Medicine (Baltimore); 2019 May; 98(21):e15793. PubMed ID: 31124974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
    Zhang C; Ren X; Liu Z; Tu C
    BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer.
    Zhang Q; Zhang Y; Wang Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30948501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
    Zhong P; Hua H; Chen S; Zhu Z; Xie F
    Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis.
    Li D; Wang R; Wu N; Yu Y
    Aging (Albany NY); 2022 Feb; 14(4):1797-1811. PubMed ID: 35183058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.